Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids

Semmler A, de Lange ME, Drenth JPH, Vermeer NS, Bet PM, Huirne JAF, Hehenkamp WJK

Therapeutics and Clinical Risk Management 2025, 21:367-382

Published Date: 19 March 2025